Home » Topics » Regulatory » Patents

Patents
RSS

Novel therapeutic agents for HIV infection disclosed in patent literature

Feb. 11, 2008

New treatment alternative for glaucoma imparted in recent Allergan patent

Feb. 11, 2008

Enanta describes new remedial option for HCV infection in a recent patent

Feb. 11, 2008

Recent Solvay patent describes new compounds for substance abuse and dependence

Feb. 8, 2008

New treatment option for Alzheimer's disease disclosed in recent Merck patent

Feb. 8, 2008

New therapeutics for thrombotic disorders reported in recent AstraZeneca patents

Feb. 8, 2008

Recent AstraZeneca patent describes novel antiarrhythmia agents

Feb. 7, 2008

Novel agents for psychological disorders disclosed in recent patent literature

Feb. 7, 2008

Recent patents report new therapeutic agents for obesity and lipoprotein disorders

Feb. 7, 2008

New therapeutic agents for diabetes described in recent patents

Feb. 6, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 27, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
Sichuan Kelun Pharmaceutical Research Institute discovers GPR6 inverse agonists
BioWorld Science
Sichuan Kelun Pharmaceutical Research Institute Co. Ltd. has identified G protein-coupled receptor 6 (GPR6) inverse agonists reported to be useful for the...